MedCon Conference 2022
May 4 – 6 — VIRTUAL
The premier medical device conference driving the speed of innovation.
Co-sponsored by the FDA
In the Healthcare Products Industry?
You Need to Be at MedCon 2022.
At MedCon, global regulators and medical device manufacturers engage to increase speed to market and
product quality through innovation.
During this virtual conference, you will:
Experience dialogue leading to practical solutions you can implement today.
Learn proactive and predictive methods to protect your products, your business, and your patients.
Gain cross-functional insights that foster critical alignment and collaboration across your organization.
Are you a current RAC holder?
Attend MedCon 2022 and earn 12.0 RAC recertification credits.
Director of the Center for Devices and Radiological Health (CDRH), FDA
Assistant Commissioner for Medical Products and Tobacco Operations, FDA-ORA
Vice President Regulatory and Quality, Abbott
Director, Regulatory Affairs, Stryker
Vice President, Global Regulatory Policy, Medtronic
OMDRHO Division 1 Director, Compliance Branch and MedCon Co-Chair, FDA-ORA
Director Quality, Global Software and Digital Health, Boston Scientific
Associate Director for Compliance and Quality, FDA – CDRH
Main Conference Sessions
Latest on FDA programs and plans, insightful speakers, roadmaps to accelerate innovation, including:
- CDRH’s Strategic Direction for 2022
- FDA Proposed QMSR – Updating 21 CFR 820 to Harmonize with ISO 13485:2016
- EU MDR Implementation: First Lessons Learned
- UK MHRA and Swiss Medic Medical Device Registrations – Are You in Compliance?
- Cybersecurity: Holistic Strategies to Mitigate and Manage Risk
- Biocompatibility and Premarket Submissions
- Global Developments in Regulating AI Based Medical Devices
- The Connected Journey of Data, Metrics, KPIs and CAPA
- Investigator Insights
- And more!
MedCon 2022 Sponsors
Because of the generosity of our sponsors, we can continue our work to improve the healthcare products industry.
Meet The New Conference Facilitators
The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Health’s legacy of delivering the MedCon Conference.
This conference is co-sponsored by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services. The contents are those of the presenters and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.